Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Kennen MacKay's Stock Ratings
RBC Capital Analyst
Kennen MacKay is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
7.43%
Smart Score
Overall Average Return Percentile
51st
Number of Ratings
66
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/17/2024 | NUVB | Buy Now | Nuvation Bio | $8.49 | -41.11% | $4 → $5 | Maintains | Outperform | Get Alert | |
| 06/27/2023 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 56.42% | $40 → $42 | Maintains | Outperform | Get Alert | |
| 08/05/2022 | AMGN | Buy Now | Amgen | $324.50 | -27.27% | $224 → $236 | Maintains | Sector Perform | Get Alert | |
| 03/21/2022 | IMGN | Buy Now | Immunogen | — | — | $9 → $6 | Downgrade | Outperform → Sector Perform | Get Alert | |
| 02/25/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 149.53% | $61 → $67 | Maintains | Outperform | Get Alert | |
| 12/21/2021 | AMGN | Buy Now | Amgen | $324.50 | -32.82% | $216 → $218 | Maintains | Sector Perform | Get Alert | |
| 12/14/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $76 → $100 | Downgrade | Outperform → Sector Perform | Get Alert | |
| 11/03/2021 | EXEL | Buy Now | Exelixis | $41.63 | -25.53% | $32 → $31 | Maintains | Outperform | Get Alert | |
| 11/03/2021 | AMGN | Buy Now | Amgen | $324.50 | -33.44% | $217 → $216 | Maintains | Sector Perform | Get Alert | |
| 11/03/2021 | ADCT | Buy Now | ADC Therapeutics | $4.18 | 713.4% | $33 → $34 | Maintains | Outperform | Get Alert | |
| 10/12/2021 | ATNX | Buy Now | Athenex | — | — | $8 → $5 | Maintains | Outperform | Get Alert | |
| 10/12/2021 | LIFE | Buy Now | aTyr Pharma | — | — | → $22 | Initiates | → Outperform | Get Alert | |
| 09/30/2021 | PRTA | Buy Now | Prothena Corp | $9.97 | 722.47% | $59 → $82 | Maintains | Outperform | Get Alert | |
| 09/27/2021 | SGEN | Buy Now | Seagen | — | — | $148 → $154 | Maintains | Sector Perform | Get Alert | |
| 09/27/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | $113 → $179 | Maintains | Sector Perform | Get Alert | |
| 08/09/2021 | ADCT | Buy Now | ADC Therapeutics | $4.18 | 689.47% | → $33 | Initiates | → Outperform | Get Alert | |
| 08/06/2021 | PBYI | Buy Now | Puma Biotechnology | $5.82 | 3.09% | $13 → $6 | Maintains | Sector Perform | Get Alert | |
| 08/06/2021 | ATNX | Buy Now | Athenex | — | — | $9 → $8 | Maintains | Outperform | Get Alert | |
| 07/29/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 68.49% | $87 → $88 | Maintains | Sector Perform | Get Alert | |
| 07/19/2021 | PRTA | Buy Now | Prothena Corp | $9.97 | 491.78% | $50 → $59 | Maintains | Outperform | Get Alert | |
| 06/11/2021 | PRTA | Buy Now | Prothena Corp | $9.97 | 401.5% | $28 → $50 | Maintains | Outperform | Get Alert | |
| 04/30/2021 | NRIX | Buy Now | Nurix Therapeutics | $19.25 | 118.18% | → $42 | Initiates | → Outperform | Get Alert | |
| 04/28/2021 | AMGN | Buy Now | Amgen | $324.50 | -33.13% | $220 → $217 | Maintains | Sector Perform | Get Alert | |
| 02/16/2021 | SGEN | Buy Now | Seagen | — | — | $186 → $169 | Maintains | Sector Perform | Get Alert | |
| 02/01/2021 | SGEN | Buy Now | Seagen | — | — | $188 → $186 | Downgrade | Outperform → Sector Perform | Get Alert | |
| 10/22/2020 | MESO | Buy Now | Mesoblast | $17.86 | -32.81% | → $12 | Initiates | → Sector Perform | Get Alert | |
| 09/15/2020 | SGEN | Buy Now | Seagen | — | — | $175 → $191 | Maintains | Outperform | Get Alert | |
| 08/20/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 76.14% | $123 → $92 | Downgrade | Outperform → Sector Perform | Get Alert | |
| 05/08/2020 | ABEO | Buy Now | Abeona Therapeutics | $5.09 | 37.5% | $11 → $7 | Maintains | Outperform | Get Alert | |
| 05/01/2020 | SGEN | Buy Now | Seagen | — | — | $148 → $149 | Maintains | Outperform | Get Alert | |
| 04/20/2020 | SGEN | Buy Now | Seagen | — | — | $121 → $147 | Maintains | Outperform | Get Alert | |
| 03/18/2020 | ABEO | Buy Now | Abeona Therapeutics | $5.09 | 116.08% | $14 → $11 | Maintains | Outperform | Get Alert | |
| 01/31/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | → $135 | Reinstates | → Outperform | Get Alert | |
| 01/24/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | — | — | Upgrade | Sector Perform → Sector Outperform | Get Alert | |
| 11/08/2019 | OBSV | Buy Now | ObsEva | — | — | $16 → $4 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/11/2019 | RARX | Buy Now | Ra Pharmaceuticals | — | — | — | Downgrade | Outperform → Sector Perform | Get Alert | |
| 04/03/2019 | MRUS | Buy Now | Merus | $96.83 | -76.25% | $18 → $23 | Upgrade | Sector Perform → Outperform | Get Alert | |
| 07/19/2018 | OBSV | Buy Now | ObsEva | — | — | → $24 | Initiates | → Outperform | Get Alert | |
| 04/23/2018 | PRTA | Buy Now | Prothena Corp | $9.97 | — | — | Downgrade | Outperform → Sector Perform | Get Alert | |
| 04/04/2018 | ANAB | Buy Now | AnaptysBio | $47.63 | — | — | Downgrade | Outperform → Sector Perform | Get Alert | |
| 02/27/2018 | OBSV | Buy Now | ObsEva | — | — | $16 → $18 | Maintains | Outperform | Get Alert | |
| 01/02/2018 | MRUS | Buy Now | Merus | $96.83 | — | — | Downgrade | Outperform → Sector Perform | Get Alert | |
| 09/15/2017 | BIVV | Buy Now | Bioverativ | — | — | → $59 | Initiates | → Sector Perform | Get Alert | |
| 09/15/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 78.06% | → $93 | Initiates | → Sector Perform | Get Alert | |
| 09/15/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | → $44 | Initiates | → Sector Perform | Get Alert | |
| 09/15/2017 | RARX | Buy Now | Ra Pharmaceuticals | — | — | → $21 | Initiates | → Outperform | Get Alert | |
| 09/15/2017 | PRTA | Buy Now | Prothena Corp | $9.97 | 772.62% | → $87 | Initiates | → Outperform | Get Alert | |
| 09/15/2017 | MRUS | Buy Now | Merus | $96.83 | -71.08% | → $28 | Initiates | → Outperform | Get Alert | |
| 09/15/2017 | KPTI | Buy Now | Karyopharm Therapeutics | $6.71 | 108.64% | → $14 | Initiates | → Outperform | Get Alert | |
| 09/15/2017 | FPRX | Buy Now | Five Prime Therapeutics | — | — | → $41 | Initiates | → Outperform | Get Alert | |
| 09/15/2017 | EXEL | Buy Now | Exelixis | $41.63 | -23.13% | → $32 | Initiates | → Outperform | Get Alert | |
| 09/15/2017 | ATNX | Buy Now | Athenex | — | — | → $35 | Initiates | → Outperform | Get Alert | |
| 09/15/2017 | ANAB | Buy Now | AnaptysBio | $47.63 | -16.02% | → $40 | Initiates | → Outperform | Get Alert | |
| 09/15/2017 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 190.5% | → $78 | Initiates | → Outperform | Get Alert | |
| 02/21/2017 | OBSV | Buy Now | ObsEva | — | — | — | Initiates | → Outperform | Get Alert | |
| 02/21/2017 | ANAB | Buy Now | AnaptysBio | $47.63 | -28.62% | → $34 | Initiates | → Outperform | Get Alert | |
| 01/23/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 104.86% | $111 → $107 | Assumes | Outperform → Outperform | Get Alert | |
| 12/12/2016 | SGEN | Buy Now | Seagen | — | — | $53 → $70 | Downgrade | Outperform → Neutral | Get Alert | |
| 03/29/2016 | PBYI | Buy Now | Puma Biotechnology | $5.82 | 518.56% | $103 → $36 | Downgrade | Outperform → Sector Perform | Get Alert | |
| 03/22/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 108.69% | $114 → $109 | Maintains | Outperform | Get Alert | |
| 03/03/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 118.27% | $110 → $114 | Maintains | Outperform | Get Alert | |
| 02/26/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 139.33% | $155 → $125 | Maintains | Outperform | Get Alert | |
| 01/20/2016 | SGEN | Buy Now | Seagen | — | — | → $52 | Initiates | → Outperform | Get Alert | |
| 06/18/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 177.62% | $125 → $145 | Maintains | Outperform | Get Alert | |
| 05/06/2015 | SGEN | Buy Now | Seagen | — | — | → $51 | Assumes | → Outperform | Get Alert | |
| 11/12/2012 | SGEN | Buy Now | Seagen | — | — | → $28 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved